Past Issues

Download Magazine



  • This field is for validation purposes and should be left unchanged.

Montefiore and Einstein in Florida 2017

Montefiore and Einstein in Florida 2017

Error: No layouts found


Montefiore and Einstein in Florida 2017

In February, Einstein and Montefiore presented three consecutive days of educational events for friends and supporters in the Palm Beach community. More than 300 people attended the gatherings, hosted by the Einstein and Montefiore Trustees.

The first event, a kickoff luncheon at the Palm Beach Country Club, was hosted by Einstein Trustees Marilyn and Stanley M. Katz. Marilyn Katz welcomed Stephen M. Safyer, M.D., president and CEO of Montefiore Medicine; Allen M. Spiegel, M.D., Einstein’s Marilyn and Stanley M. Katz Dean; and the many Einstein and Montefiore Trustees. Kamran Khodakhah, Ph.D., chair of the Dominick P. Purpura Department of Neuroscience, gave a presentation, “The Brain: The Essence of Our Being.” The afternoon concluded with a lively question-and-answer session.

The next evening, Einstein Trustee Karen Mandelbaum and her husband, David, hosted cocktails in their home in Jupiter. Steven C. Almo, Ph.D., the Wollowick Family Foundation Chair in Immunology and director of Einstein’s Macromolecular Therapeutics Development Facility, gave a presentation, “New Strategies for Immunotherapy: Releasing the Power Within.”

The weekend concluded with a sunset reception at the beachfront home of Montefiore Trustee Melissa Ceriale and her husband, John. This event included a presentation by Evan S. Garfein, M.D., chief of the division of plastic and reconstructive surgery at Montefiore and associate professor of both surgery and otorhinolaryngology at Einstein, “Conjoined Twins: Uniting Clinical Excellence and Innovation.”


More From Einstein

Class of 2024 Celebrates Match Day
Einstein Community Enjoys Pi Day
Graduate Students Win Marmur Award
Empowering Einstein Women in Science
Einstein Secures $192M in NIH Grants
Training the Next Cancer Researchers
Bringing a Novel Drug to Market
A Promise to Rwandan Genocide Survivors